Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is trading at $7.65, about ₹735 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, up 0.26% today. Indian residents can buy Maravai LifeSciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$7.43
Today's high
$7.67
52 week low
$2.55
52 week high
$9.42
MRVI opened at $7.52, closed previously at $7.63, and has traded between $2.55 and $9.42 over the past 52 weeks.
About
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for detecting impurities in biopharmaceutical manufacturing, and tools for monitoring protein expression across different tissue types. The company conducts its operations through two distinct segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment specializes in manufacturing and distributing products integral to gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics. This encompasses reagents utilized in the chemical synthesis, modification, labeling, and purification of DNA and RNA. Additionally, this division provides messenger RNA, oligonucleotides, their foundational building blocks, plasmid DNA, and the proprietary CleanCap capping technology. Meanwhile, the Biologics Safety Testing segment offers analytical products vital for developing biologic manufacturing processes. Its offerings include bespoke antibody and assay development services tailored to specific products, alongside HCP ELISA kits, various other ELISA kits for identifying bioprocess impurities and contaminants, ancillary reagents, and custom service solutions. Maravai's clientele spans biopharmaceutical companies, other life sciences and biopharmaceutical research firms, academic research institutions, and in vitro diagnostics companies. Incorporated in 2020, Maravai LifeSciences Holdings, Inc. maintains its headquarters in San Diego, California.
Key statistics
Avg. volume
3.25M
Market cap
$2.11B
P/E Ratio
-14.29
Price-to-sales ratio
10.12
Enterprise value
$716.28M
Free cash flow yield
-15.00%
Debt-to-equity ratio
0.86
Return on equity
-61.58%
ROIC
-0.91%
Beta
0.60
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$185.74M
Earnings per share
-$0.91
Free cash flow
-$70.72M
Net profit margin
-37.07%
Gross margin
34.61%
EBITDA
-$147.11M
Revenue growth
-28.34%
Similar securities
This is not an investment recommendation
How to buy Maravai LifeSciences from India
Indian residents can buy Maravai LifeSciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Maravai LifeSciences and place an order
Find Maravai LifeSciences by name or by its ticker, MRVI, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Maravai LifeSciences trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Maravai LifeSciences position in USD and INR. Maravai LifeSciences pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Maravai LifeSciences from India
Trading and taxes when buying Maravai LifeSciences from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneMaravai LifeSciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Maravai LifeSciences stock?
Yes. Maravai LifeSciences (MRVI) has been listed on NASDAQ since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Maravai LifeSciences share cost in rupees?
One Maravai LifeSciences share is $7.65 — about ₹735 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Maravai LifeSciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Maravai LifeSciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Maravai LifeSciences?
Yes. One Maravai LifeSciences share is $7.65, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Maravai LifeSciences.
How are gains on Maravai LifeSciences shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Maravai LifeSciences price. Paasa issues a capital-gains statement for your return.
Does Maravai LifeSciences pay a dividend?
No. Maravai LifeSciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Maravai LifeSciences from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Maravai LifeSciences shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Maravai LifeSciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Maravai LifeSciences holding, its cost and its closing value.
How do I sell Maravai LifeSciences and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.